Hims Hers Health Inc is trading 5.5% down today at $26.48 as the stock pulls back following a sharp multi-day rebound tied to the reassessment of its $1.15 billion Eucalyptus acquisition and GLP-1 strategy.
- The move appears to be normal volatility following recent strength, especially as options markets had priced in a wide ±7.52% weekly move.
- Broader market indices are also trading lower, suggesting the decline is a mix of company-specific digestion and general risk-off sentiment.